Myomo, Inc. Securities Sold under Agreements to Repurchase
Myomo, Inc. (MYO) had Securities Sold under Agreements to Repurchase of $5.00 million as of 2023-01-31, per its 10-Q filed 2023-08-09.
Discontinued › Balance Sheet › Liabilities
us-gaap:SecuritiesSoldUnderAgreementsToRepurchase · last filed 2023-08-09
- 2023-01-31: Securities Sold under Agreements to Repurchase $5.00M.
| Period end | Securities Sold under Agreements to Repurchase |
|---|---|
| 2023-01-31 | $5.00M 10-Q · filed 2023-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| ENvue Medical, Inc. (FEED) | United States | $0.011B | |
| Bone Biologics Corp (BBLG) | United States | $0.001B |